All team members
Dr. Naho Fujimoto
Partner
German Patent Attorney
European Patent Attorney
UPC Representative
Chemist
Naho advises and represents companies from the pharmaceuticals and chemicals industries with respect to patent prosecution proceedings worldwide. On account of her linguistic and cultural background, Naho’s Japanese clients naturally make up a large part of her workload, which have a focus on Europe. Naho also supervises and manages complex global patent families and portfolios, from filing to grant to post-grant procedures.
She has many years of experience in providing strategic advice on product-related projects, including conducting state of the art searches, preparing freedom-to-operate opinions, monitoring competitor activities, supporting clients in licensing negotiations and participating in opposition and appeal proceedings.
“Naho Fujimoto is an extremely thoughtful patent lawyer and exceptional prosecutor. She drafts complex applications and provides guidance to her clients on how to obtain the strongest protection possible in crowded spaces.”
– IAM Strategy 300, 2024
"Naho Fujimoto is a fluent Japanese speaker with a large and sophisticated practice for Japanese pharmaceutical and biotech names seeking protection in Europe. Strategically minded and sharp, she provides high-level portfolio advice, conducts comprehensive searches and prepares FTO analyses."
– IAM Patent 1000, 2023
"Naho Fujimoto: Very solution-oriented; very efficient."
– Legal 500 DE, 2022
“Through careful white space analyses and a deep understanding of the prior art landscape as well as a remarkable knowledge of the pharmaceutical industry, Naho Fujimoto anticipates possible hurdles and develops thoughtful strategies that maximise her client’s opportunities.”
– IAM 300, 2022
“Naho Fujimoto is a terrific prosecutor who provides excellent advice and clear guidance on European patent matters. She is an incredibly strategic thinker and a superb advisor.”
– IAM Strategy 300, 2023
"Naho Fujimoto is a commercially minded adviser who has built strong relationships with Japanese companies seeking to secure patent protection in Europe. She makes all the right plays to help her clients establish and entrench strong positions in new markets."
– IAM Patent 1000, 2024
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity analysis
- Opposition and nullity proceedings
- Recommended as one of the world's leading intellectual property strategists by IAM Strategy 300 2021, 2022, 2023, 2024
- Listed as "Highly recommended" in the Healthcare & Pharmaceuticals category in the Leaders League Rankings Germany 2024
- Recommended in Legal 500 EMEA 2021, 2022, 2023, 2024
- Recommended in Legal 500 Deutschland 2021, 2022, 2023, 2024
- Listed in IAM Strategy 300 Global Leaders 2022, 2023, 2024, 2025
- Recommended in IAM Patent 1000 “World’s Leading Patent Professionals” 2023
- Scholarship from the German National Academic Foundation
- Interview IAM Strategy 300 Global Leaders, 2024
- Promoting women and young talent at MAIWALD, 2024
- Antibody patents in Europe – The level of disclosure required for functional claims, Intellectual Property Management Vol. 73 No. 6 pp. 690-702 (Japanese only), 2023
- Interview IAM Strategy 300 Global Leaders, 2023
- Article new EPO Guidelines 2021 and VC, AIPPI Japan Vol66 No12 (Japanese only)
- German Patent Attorney Association
- epi
- GDCh
- German
- Japanese
- English
- French
